Joint effects of prothrombotic genotypes and body height on the risk of venous thromboembolism: the Tromsø study
- PMID: 29094466
- DOI: 10.1111/jth.13892
Joint effects of prothrombotic genotypes and body height on the risk of venous thromboembolism: the Tromsø study
Abstract
Essentials Body height and prothrombotic genotypes are associated with risk of venous thromboembolism (VTE). The joint effect of prothrombotic genotypes and tall stature on VTE risk is scarcely investigated. We investigated the joint effect of prothrombotic genotypes and tall stature on VTE risk. Prothrombotic genotypes did not yield excess risk of VTE in subjects with a tall stature.
Summary: Background Studies have reported synergistic effects of prothrombotic single-nucleotide polymorphisms (SNPs) and obesity on the risk of venous thromboembolism (VTE). Tall stature is associated with an increased VTE risk, but the joint effect of prothrombotic genotypes and tall stature on the VTE risk is unknown. Aims To investigate the joint effects of prothrombotic genotypes and tall stature on the VTE risk. Methods Cases with incident VTE (n = 676) and a randomly selected age-weighted subcohort (n = 1842) were sampled from the Tromsø study (cohort follow-up: 1994-2012). DNA was genotyped for rs6025 (factor V Leiden), rs1799963 (FII), rs8176719 (ABO blood group), rs2066865 (fibrinogen-γ), and rs2036914 (FIX). Age-adjusted and sex-adjusted hazard ratios (HRs) of VTE were calculated by categories of risk alleles (de Haan 5-SNP score: 0-1, 2-3, and ≥ 4) and body height (< 40th, 40th-80th and > 80th percentiles). Results The VTE risk increased by increasing category of body height, and subjects with height ≥ 178 cm had a two-fold higher VTE risk (HR 2.03; 95% confidence interval [CI] 1.51-2.73) than those with height ≤ 165 cm. The VTE risk also increased across categories of risk alleles. However, the combination of a tall stature and risk alleles, either individual SNPs or risk score, did not result in an excess VTE risk. Subjects with four or more risk alleles and height ≥ 178 cm had a two-fold (HR 2.08; 95% CI 1.24-3.52) higher VTE risk than subjects ≤ 165 cm with no risk allele or one risk allele. Conclusions In contrast to obesity, the presence of prothrombotic genotypes did not result in an excess VTE risk in subjects with a tall stature.
Keywords: SNPs; body height; cohort; risk; venous thromboembolism.
© 2017 International Society on Thrombosis and Haemostasis.
Similar articles
-
Impact of prothrombotic genotypes on the association between family history of myocardial infarction and venous thromboembolism.J Thromb Haemost. 2019 Aug;17(8):1363-1371. doi: 10.1111/jth.14493. Epub 2019 Jun 7. J Thromb Haemost. 2019. PMID: 31124268
-
Effect of prothrombotic genotypes on the risk of venous thromboembolism in patients with and without ischemic stroke. The Tromsø Study.J Thromb Haemost. 2019 May;17(5):749-758. doi: 10.1111/jth.14410. Epub 2019 Mar 12. J Thromb Haemost. 2019. PMID: 30773804
-
Joint Effect of Multiple Prothrombotic Genotypes and Obesity on the Risk of Incident Venous Thromboembolism.Thromb Haemost. 2022 Feb;122(2):267-276. doi: 10.1055/a-1497-9777. Epub 2021 Jun 25. Thromb Haemost. 2022. PMID: 33940655
-
Combined oral contraceptives, thrombophilia and the risk of venous thromboembolism: a systematic review and meta-analysis.J Thromb Haemost. 2016 Jul;14(7):1393-403. doi: 10.1111/jth.13349. Epub 2016 Jun 16. J Thromb Haemost. 2016. PMID: 27121914 Review.
-
Recommendations from the EGAPP Working Group: routine testing for Factor V Leiden (R506Q) and prothrombin (20210G>A) mutations in adults with a history of idiopathic venous thromboembolism and their adult family members.Genet Med. 2011 Jan;13(1):67-76. doi: 10.1097/GIM.0b013e3181fbe46f. Genet Med. 2011. PMID: 21150787
Cited by
-
Association between cardiovascular risk factors and venous thromboembolism in the elderly.Res Pract Thromb Haemost. 2022 Mar 1;6(2):e12671. doi: 10.1002/rth2.12671. eCollection 2022 Feb. Res Pract Thromb Haemost. 2022. PMID: 35252737 Free PMC article.
-
New Mechanisms of Bromelain in Alleviating Non-Alcoholic Fatty Liver Disease-Induced Deregulation of Blood Coagulation.Nutrients. 2022 Jun 1;14(11):2329. doi: 10.3390/nu14112329. Nutrients. 2022. PMID: 35684129 Free PMC article.
-
Proportion of venous thromboembolism attributed to recognized prothrombotic genotypes in men and women.Res Pract Thromb Haemost. 2024 Feb 8;8(2):102343. doi: 10.1016/j.rpth.2024.102343. eCollection 2024 Feb. Res Pract Thromb Haemost. 2024. PMID: 38476459 Free PMC article.
-
Epidemiology and Genetics of Venous Thromboembolism and Chronic Venous Disease.Circ Res. 2021 Jun 11;128(12):1988-2002. doi: 10.1161/CIRCRESAHA.121.318322. Epub 2021 Jun 10. Circ Res. 2021. PMID: 34110897 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous